The government’s Rs 1,500 crore bet on Biological E’s vaccine candidate that is still undergoing trials may be a risk worth taking, experts said but an industry executive said the money should have been used to buy vaccines already in the marketIs the govt taking a risk on Bio E vaccine that#39;s yet to cross the finish line?
The government’s Rs 1,500 crore bet on Biological E’s vaccine candidate that is still undergoing trials may be a risk worth taking, experts said but an industry executive said the money should have been used to buy vaccines already in the market
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment